Więcej o książce
The only available text to focus primarily on Acute Respiratory Distress Syndrome (ARDS). Thoroughly revised content and ten new chapters provide pulmonologists with the latest developments and applications of pharmacological and mechanical therapies needed to treat the debilitating and difficult condition of ARDS. Highlights include: the definition, epidemiology, pathology, and pathogenesis of ARDS complications such as transfusion-related injury, and endothelium and vascular dysfunction the long-term outcomes of ARDS host defense and infection the latest developments in ARDS therapy: glucocorticoid therapy, surfactant therapy, mechanical ventilation, and mesenchymal stem cells predictive factors: gene expression profiling and biomarkers, and chemokines and cytokines advances in management strategies: fluid management, non-pulmonary and non-sepsis management, and glucose control
Zakup książki
Lung Biology in Health and Disease - 233: Acute Respiratory Distress Syndrome, Augustine M. K. Choi, Thomas Martin, Michael A. Matthay, Robert M. Strieter, Claude Lentant
- Język
- Rok wydania
- 2017
- Oprawa
- (miękka),
- Stan książki
- Bardzo dobry
- Cena
- 62,59 zł
Metody płatności
Nikt jeszcze nie ocenił.
- Tytuł
- Lung Biology in Health and Disease - 233: Acute Respiratory Distress Syndrome
- Podtytuł
- Second Edition
- Język
- angielski
- Wydawca
- CRC Press
- Rok wydania
- 2017
- Oprawa
- miękka
- Liczba stron
- 480
- ISBN10
- 113811541X
- ISBN13
- 9781138115415
- Seria
- Kategorie
- Opis
- The only available text to focus primarily on Acute Respiratory Distress Syndrome (ARDS). Thoroughly revised content and ten new chapters provide pulmonologists with the latest developments and applications of pharmacological and mechanical therapies needed to treat the debilitating and difficult condition of ARDS. Highlights include: the definition, epidemiology, pathology, and pathogenesis of ARDS complications such as transfusion-related injury, and endothelium and vascular dysfunction the long-term outcomes of ARDS host defense and infection the latest developments in ARDS therapy: glucocorticoid therapy, surfactant therapy, mechanical ventilation, and mesenchymal stem cells predictive factors: gene expression profiling and biomarkers, and chemokines and cytokines advances in management strategies: fluid management, non-pulmonary and non-sepsis management, and glucose control